ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Rabbit Anti-Thymocyte Globulin versus Anti-T Lymphocyte Globulin Rescue Therapies in Delayed Graft Function after Kidney Transplantation from Donors after Cardiac Death

    H. Yang1, Y. Shi2, X. Li1, C. Long1, H. Li3, Z. Wang3

  • Racial and Ethnic Disparities in Access to Liver Transplantation in the United States

    A. Zarrinpar, C. Warren, K. Andreoni, M. Johnson, N. Battula

  • Racial Differences in Acceptance of Public Health Service (PHS) Increased Risk Kidneys and Hepatitis C (HCV) Nat Positive Kidneys

    K. Atiemo, S. Giusti, A. Paramesh, M. Killackey, H. Jeon

  • Racial Disparities in Access to Kidney Transplantation in New York City

    J. Torabi, M. Parides, J. A. Graham, J. P. Rocca

  • Racial Disparities in Liver Transplant Outcomes Are Consistent Regardless of Transplant Center Characteristics in the United States

    K. Ross, R. Lynch, R. Patzer

  • Racial Disparities in Long-Term Outcomes in Kidney Transplantation from Elderly Donors in United States

    S. Shah, B. Abu Jawdeh, S. Bumb, T. Kaur, M. Anand, A. Govil, R. Jain

  • Racial/Ethnic Differences in Deceased Organ Donor Rates Over Time in the United States

    A. Kernodle, W. Zhang, B. Doby, L. Liyanage, A. Massie, T. Purnell, D. Segev

  • Ranking Eplet Mismatches as Predictors of Graft Failure

    W. Zhang1, H. Mohammadhassanzadeh1, K. Oualkacha2, H. Gebel3, W. Klement4, R. Sapir-Pichhadze1

  • Rapid Preparation to Undergo ABO-Incompatible Living Donor Liver Transplantation for Acute Liver Failure

    H. Hung1, C. Lee2, Y. Wang1, J. Lee2, C. Cheng1, T. Wu1, T. Wu1, H. Chou1, K. Chan1, W. Lee2

  • Rare Case of Donor Transmission of Hepatitis a Virus in Two Kidney Transplant Recipients

    A. Kumar, S. Rao, A. Nishio Lucar, C. Argo, M. Poulter, A. Doyle

  • Rare Genetic Mutation Triggering Acute Liver Failure in a Toddler Needing a Liver Transplant

    C. B. Chen1, N. Mistry Ambani1, A. Zeft1, R. Garcia-Naviero2, V. Hupertz1, K. Hashimoto1, K. Radhakrishnan1

  • Rare HLA DRB1*10-DQB1*06 Linkage Disequilibrium: A Case Study That Emphasizes the Need of Having an HLA Toolbox

    S. Dionne, L. Santiago, S. Shetty

  • Rat Hind Limb Transplant Model to Assess Vascularized Composite Allograft (VCA) Inflammation and Ischemia Reperfusion Injury

    Z. Wang1, A. B. Harrant1, Y. Wang1, K. Washington1, E. Farkash2, C. A. Huang1

  • Rate of Change in Body Mass Index Prior to Liver Transplantation is Independently Associated with Post-Transplant Survival

    N. Mahmud1, Y. Saiman1, M. Serper1, E. Weinberg1, K. Rothstein1, D. Goldberg2

  • Rates of Live Donor Liver Transplantation Vary by Socioeconomic Status and Geography

    D. R. Jorgensen, A. Humar, C. Hughes, M. Molinari, A. Ganoza, S. Ganesh, A. Duarte-Rojo, A. Tevar

  • Rates of Urinary Tract Infections in Kidney Transplant Patients Using Trimethoprim/Sulfamethoxazole versus Alternative Agents for Pneumocystis Jiroveci Prophylaxis

    L. C. Laird, R. M. Nygaard, T. L. Anderson-Haag, A. M. Spenningsby, P. A. Stahler

  • Re-Establishing Abstinence after Alcohol Relapse after Early Transplant (LT) for Alcoholic Hepatitis (AH) Provides Survival Advantage

    J. Rice1, B. Lee2, G. Therapondos3, G. Im4, A. Lazar2, M. Lucey1, E. Weinberg5, H. Han6, H. Maddur7, M. Ghobrial8, C. Hsu9, O. Fix10, S. Eswaran11, K. Shetty12, N. Jakhete12, D. Victor8, D. Foley1, N. Mehta2, M. Rinella7, T. Schiano4, C. Mobley8, N. Terrault6

  • Re-Examining Sex-Based Differences in Liver Transplant Outcomes for HCV Cirrhosis

    D. Yoeli1, R. Choudhury1, H. Moore1, A. Sauaia1, M. Simpson2, E. Pomfret1, T. Nydam1

  • Re-Transplantation (Tx) in Pediatric Patients with Failure of Primary Transplant (Tx) Due to Recurrent Focal Segmental Glomerulosclerosis (FSGS). A Pediatric Nephrology Research Consortium (PNRC) Study

    A. Maniar1, D. Hooper2, C. Sethna1, P. Singer1, A. Z. Traum3, E. Kotzen4, K. Sanderson4, P. S. Verghese5, S. I. Al-Akash6

  • Re-Transplantation Outcomes in the United States Before and after DAA-Introduction

    T. Ivanics, M. Rizzari, A. Al-Kurd, T. Kitajima, A. Elsabbagh, K. Collins, A. Yoshida, M. Abouljoud, S. Nagai

  • Reactivation of BK Polyomavirus after Kidney Transplantation: A Multi-Center Collaboration Examining the Impact of Adherence to a Screening Protocol on Clinical Outcomes

    R. Rogers1, F. Cheema2, M. Chobanian3, Z. Ebcioglu2, H. Gilligan4, R. Gohh1, N. Goyal5, M. Pavlakis6, N. Rodig7, A. Rossi8, J. Singh2, C. S. Tan6

  • Reactivation of Murine Polyomavirus Replication by Renal Ischemia-Reperfusion Injury and Immunosuppression

    G. Huang1, Y. Huang1, X. Chen1, J. Qiu1, J. Li1, G. Li2, C. Wang1, L. Chen1

  • Readmission Outcomes of Bariatric Surgery in Liver Transplant Recipients

    R. A. Choudhury1, D. Yoeli1, H. Yaffe1, H. B. Moore1, G. Hoeltzel2, A. Schulick1, P. L. Abt3, K. Dumon4, K. D. Conzen1, J. J. Pomposelli1, E. A. Pomfret1, T. L. Nydam1

  • Ready for Transplantation: Getting the Right Messages Across at the Right Time

    D. Goodall, K. Tansey, S. Clarke-Swaby, P. Webster, E. Salisbury, J. Tomlinson, R. Bright, W. Brown

  • Real-Time Viability Assessment During Normothermic Machine Perfusion with Resonance Raman Spectroscopy

    R. J. De Vries1, S. Raigani1, P. Romfh2, S. E. Cronin1, C. A. Pendexter1, C. Carroll1, T. M. Van Gulik3, P. Chen2, K. Uygun1, H. Yeh1, S. N. Tessier1

  • Real-World Experiences in the Transplantation of Hepatitis C Positive Kidneys

    J. M. Steinbrink, J. Byrns, L. Crona, M. Ellis, S. Sanoff, E. K. Maziarz, C. R. Wolfe

  • Reasons for Living Kidney Donor Candidate Turndowns: A Single-Center Cohort Study

    M. Debroy, K. Yadav, A. Palanisamy, K. Chavin

  • Recipient and Donor Factors Associated with Post-Donation ESRD in Related White Living Kidney Donors

    J. Wainright1, A. Robinson1, A. Wilk1, D. Klassen2, W. Cherikh1, L. Cartwright1, D. Stewart1

  • Recipient Expression of C-Type Lectin Receptor Mincle Promotes Rapid T Cell Homeostatic Recovery Following Antibody Mediated Lymphoablation

    S. Hasgur, R. Fan, A. Valujskikh

  • Recipient LAG3 Deficiency Results in Antibody-Mediated Rejection of Mouse Renal Allografts

    M. Nicosia, R. Fan, J. Lee, V. Gorbacheva, A. Beavers, N. Dvorina, W. M. Baldwin III, R. L. Fairchild, B. Min, A. Valujskikh

  • Recipient Myeloid Cell Myeloperoxidase is Required for Nk Cell Activation During Antibody-Mediated Allograft Rejection

    S. Miyairi, N. Dvorina, K. S. Keslar, A. Valujskikh, W. M. Baldwin, R. L. Fairchild

  • Recipient Outcomes of DCD Kidneys with and without Donor TPA Administration

    E. Shipman, W. De Faria, L. Preczewski, R. Vianna, G. Guerra

  • Recruitment in the Pediatric Heart Transplant TEAMMATE Trial: Observed vs. Expected

    K. P. Daly, L. A. Sleeper, L. J. Addonizio, J. C. Alejos, S. Auerbach, M. J. Bock, A. Butto, W. F. Carlo, C. Castleberry, W. J. Dreyer, B. Feingold, J. M. Lamour, E. L. Albers, S. A. Hollander, G. L. Klein, A. Lal, E. Pahl, D. Peng, A. R. Punnoose, J. W. Rossano, T. D. Ryan, J. Su, D. L. Sutcliffe, S. Zangwill, C. S. Almond

  • Recruitment of Regulatory T Cells Promotes Donor-Specific Tolerance in Vascularized Composite Allotransplantation

    J. D. Fisher1, W. Zhang2, S. C. Balmert3, A. M. Aral1, Y. Kulahci4, A. P. Acharya4, J. Li2, H. R. Turnquist5, A. W. Thomson5, M. G. Solari2, V. S. Gorantla6, S. R. Little4

  • Recurrence of IgA Nephropathy after Kidney Transplantation – Tango Multicenter Study

    A. Uffing1, P. Cravedi2, L. V. Riella1

  • Recurrence of Igg3Lambda Restricted Cryoglobulinemic Glomerulonephritis in a Renal Allograft: Resolution after Daratumumab Treatment

    S. C. Jordan, R. Vescio, J. Hou, N. Ammerman, R. Najjar, S. Sethi, E. Huang, A. Peng, A. Vo

  • Recurrent Diabetic Nephropathy Post Kidney Transplant is Associated with High Risk of Mortality

    A. Kukla, M. Merzkani, W. Park, B. Smith, S. Turkevi-Nagy, P. Zhang, X. Benavides, M. Morales Alvarez, A. Denic, A. Bentall, Y. Kudva, M. D'Costa, P. Alexander, M. Stegall

  • Recurrent Focal Segmental Glomerulosclerosis and the Possibility of Re-Transplantation

    E. L. Wood1, J. Burrows1, E. Lum, MD2, J. Veale, MD1

  • Recurrent Lupus Post Kidney Transplantation- The Histological and Clinical Characteristics

    A. Bentall1, W. Jiqiu2, A. Kattah1, M. L. Gonzalez Suarez3, F. G. Cosio1, M. Mai4, H. Khamash5, M. D. Stegall6, H. Amer1, L. D. Cornell7, F. Fervenza1, M. P. Alexander7

  • Reduced Dose of Mycophenolate Mofetil as Well as Preformed DSA Are Risk Factors Associated with the Development of Chronic Active Antibody Mediated Rejection after Kidney Transplantation: A Retrospective Case Control Study

    K. Shinoda1, H. Oguchi1, K. Nishikawa1, T. Yonekura1, M. Muramatsu1, T. Kawamura1, Y. Hamasaki1, T. Mikami2, K. Sakai1, S. Shishido1

  • Reduced Dose Valganciclovir is Effective for CMV Prevention without Excess Breakthrough or Resistance in Kidney Transplantation

    M. Luu1, P. Klem1, B. Crowther1, M. Abidi2, M. Miller1, K. Schoeppler1, S. Davis2

  • Reducing Travel While Improving Geographic Equity: Continuous Distribution with “Gravity Functions”

    M. Mankowski1, N. Wood2, S. Gentry2, D. Segev3

  • Reduction in Physician Burnout among Transplant Surgeons: A Preliminary Result of the Role of ‘Medical Missions’

    N. T. Ngo1, D. Halpin2, P. Sindhwani3, O. Ekwenna3

  • Reduction in UTI and UTI-Related Hospitalizations with Antibiotic Prophylaxis for Stent Removal in Kidney Transplant Recipients

    K. D. Belfield1, J. D. Smith2, L. F. Borges3, M. Malinis4

  • Regulatory T Cell-Derived Amphiregulin Activates Fibroblasts to Promote Chronic Rejection after Heart Transplantation

    L. Fan1, X. Zhang1, T. Li1, L. R. Mathews1, G. K. Dwyer2, M. J. Calderon3, K. E. Helfrich3, M. A. Ross3, S. C. Watkins3, H. R. Turnquist1

  • Regulatory T Cells Engineered with TCR-Signaling-Responsive Il-2 Nanogels Suppress Alloimmunity in Sites of Antigen Encounter

    S. K. Eskandari1, J. B. Alhaddad1, I. Sulkaj2, M. B. Melo2, N. Li2, H. Allos1, B. Kollar1, M. A. Seelen3, D. J. Irvine4, J. Azzi1

  • Relapse-Prone Unresectable Hepatoblastoma (HB) Requiring Liver Transplantation (LT) Are Immunogenic and May Be Sensitive to Immune Checkpoint Inhibitors

    M. Ningappa1, C. Ashokkumar1, J. Garifallou2, M. Gonzalez2, H. Hakonarson2, S. Ranganathan1, B. W. Higgs1, R. Sindhi1

  • Relationship between Tacrolimus Intrapatient Variability and Medication Adherence in Kidney Transplant Recipients

    A. D. Leino, K. Abuls, J. L. Rodgers, K. Kuntz

  • Relationship between Tacrolimus Levels and Short-Term Outcome in Korean Pediatric Patients with Liver Transplantation

    H. Lim1, H. Koh1, S. Kim1, S. Park1, Y. Kang2, M. Kim3, K. In1

  • Relative Transplant Center Organ Volumes are Associated with Patient and Graft Survival

    J. T. Adler, T. C. Tsai, S. K. Malek, S. G. Tullius, J. S. Weissman

  • Remote Steroid Wean is Safe When Compared to Early Wean in Heart Transplant Recipients

    B. C. Salgado, J. Krisl, E. A. Graviss, D. T. Nguyen, A. Bhimaraj, A. Guha

  • Renal Allograft Outcome from Hypertensive Donor: Comparison between Living and Deceased Donor

    H. Hwang1, J. Kong1, J. Kim1, Y. Kim1, J. Moon1, K. Jeong1, S. Song2, S. Song3, H. Shin4, J. Yang5, C. Ahn6, Y. Lee7, S. Lee1

  • Renal Allograft Surveillance with Allospecific T-cytotoxic Memory Cells Which Express CD154

    V. Rohan, A. Alqassieh, N. Patel, K. Soliman, V. Rao

  • Renal Function Parameters Improve PELDs Prediction of 90-day Death or Deterioration

    L. Thalji1, N. Thalji2, D. Haile1, J. Heimbach2, S. Ibrahim3, P. Kamath4, D. Kor1

  • Renal Immunoproteasome Function: A Possible Cause for Macrophage Associated Organ Damage During Renal Transplantation?

    N. Parajuli, A. Khakurel

  • Renal Safety of Entecavir and Tenofovir with Hepatitis B Immunoglobulin in Liver Transplant Patients

    J. Lee1, E. Kim1, S. Yang1, D. Kim2, S. Kim1, J. Park3, H. Choi4, B. Kim3, D. Joo1, M. Kim1, S. Kim1, J. Lee1

  • Renal Transplant Induction Therapy Safety Outcomes Comparison

    R. M. Hofmann1, J. Combs2, K. J. Schmidt3, T. Dyckman4

  • Renal Transplantation in Jehovah’s Witnesses: A Single-Center Experience

    J. Rao, A. Matas, S. Jackson, V. Humphreville

  • Renal Transplantation Into Urinary Diversions and Reconstructed Bladders

    J. J. Chong, R. H. Zakri, S. Khan, G. Koffman, N. Mamode, J. Olsburgh

  • Renoportal Vein Graft for Complete Portal Vein Thrombosis: A Reproducible Technique for a Challenging Problem

    P. Mehta, M. Black, H. Fernandez, J. Bayer, A. Gupta, A. Wall, E. Martinez, N. Onaca, R. Ruiz, G. Testa, G. J. Mckenna

  • Report of Organ Offers Linked with Instant Messaging Data Provides a Basis for Quality Improvement

    E. Pahl

  • Resilience in Heart Transplant Candidates

    Y. T. Bui1, D. S. Yip2, B. W. Hardaway3, S. M. Dunlay4, S. Jowsey-Gregoire5, R. Benzo6, R. C. Daly7, M. A. Hathcock8, K. Thompson9, C. C. Kennedy10

  • Results of a Prospective Pilot Program for Transplantation of Patients with Alcohol-Related Liver Disease and Less Than 6 Months Abstinence

    J. Quance, L. Carrique, I. Sales, L. Lilly, M. Bhat, Z. Galvin, A. Tan, S. Abbey, J. Lynch, N. Selzner

  • Results of Pancreas Transplantation in Diabetic Patients with End-Stage Kidney Disease Older Than 50 Years

    E. Montagud-Marrahi1, A. Molina2, A. Pané3, M. Ramirez-Bajo4, A. Amor3, E. Esmatjes3, J. Ferrer5, F. Diekmann1, P. Ventura-Aguiar1

  • Retinal Vein Occlusion Incidence in Kidney Transplant Recipients in South Korea: A Long-Term Population-Based Study

    J. Lee1, S. Park1, J. Kim1, M. Yu2, S. Baek3, K. Han4, D. Kim1, K. Joo1, Y. Kim1, H. Lee1, Y. Kim1

  • Retroperitoneoscpic Donor Nephrectomy in the Right Side Provides Excellent Outcomes and Donor Safety Comparable with Left Side

    D. Iwami, K. Hotta, N. Iwahara, N. Shinohara

  • Reverse Epidemiology and the Obesity Paradox for Patients with Chronic Kidney Disease

    R. A. Choudhury1, D. Yoeli1, H. B. Moore1, H. Yaffe1, G. Hoeltzel2, K. R. Dumon3, N. N. Williams3, P. L. Abt4, K. D. Conzen1, T. L. Nydam1

  • Risk Aversion in Lung Transplantation: Organ Procurement Organizations Differ in Willingness to Pursue Non-Ideal Donor Organs

    S. E. Halpern1, A. McConnell2, S. Peskoe2, V. Raman3, O. K. Jawitz3, A. Y. Choi1, J. C. Haney3, J. A. Klapper3, M. G. Hartwig3

  • Risk Epitope Mismatch Does Not Predict Short Term Heart Transplant Outcomes

    Y. Moayedi1, J. McCaughan2, E. Henricksen3, B. Mueller4, S. Fan4, H. J. Ross1, K. Khush5, B. M. Zhang6, J. Teuteberg5

  • Risk Factors and Treatment of Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation

    G. Chen, C. Wang, Z. Wu, X. Liu, Q. Li, L. Chen

  • Risk Factors Associated with Hepatic Artery Thrombosis in the Modern Era

    M. Krach, A. Kernodle, P. Chiang, D. Segev, A. Massie, J. Garonzik-Wang

  • Risk Factors for Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Adult Patients of Respiratory Tract within 90 Days after Lung Transplantation

    W. Chen, L. Zhao, L. Guo, S. Du, C. Liang, M. Li, B. Cao, B. Lu, J. Chen, C. Wang

  • Risk Factors for Adverse Clinical Outcomes amongst Renal Transplant Candidates Undergoing Screening Angiography for Coronary Artery Disease

    M. Shah1, A. Yung1, J. Ebinger1, J. Mirocha2, E. Huang3, D. Geft1, A. Peng3, B. Azarbal1

  • Risk Factors for Antibody-Mediated Rejection after Adult Liver Transplantation with Preformed Donor-Specific Antibodies: A Single Center Experience

    T. Tajima, K. Hata, J. Kusakabe, H. Miyauchi, T. Anazawa, T. Ito, S. Uemoto

  • Risk Factors for Bacterial or Candidal Donor-Derived Infections among Solid Organ Transplant Recipients

    J. A. Anesi1, E. Lautenbach1, J. H. Han2, D. H. Lee3, H. Clauss4, R. Hasz5, E. Molnar4, D. Alimenti1, A. R. Motzer4, S. West5, W. B. Bilker1, P. Tolomeo1, E. A. Blumberg1, T. Prevention Epicenters Program6

  • Risk Factors for BK Virus Infection after Kidney Transplantation in the Contemporary Era: A Single-Centre Observational Study

    N. Phagura1, K. Thandi1, F. Evison2, S. Gallier2, A. Sharif3

  • Risk Factors for Early Graft Loss and Mortality in Pancreas Transplant Recipients: A Multivariate Analysis of U.S. Transplants

    S. M. Riad1, A. Adamusiak2, S. Jackson3, E. B. Finger2, R. Kandaswamy2

  • Risk Factors for Early Multidrug-Resistant Infections in Solid Organ Transplant Recipients: How Impactful Are Donor-Derived Infections?

    T. T. Miller1, E. J. Kwak2, G. Floridia3, F. Tuzzolino3, A. Luca3, A. Mularoni3

  • Risk Factors for Failing Native Kidney Function after Successful PTA

    A. Gruessner, S. Saggi, J. Renz, R. Gruessner

  • Risk Factors for Hepatic Artery Thrombosis: A Single Center Study with Multiple Surgeons

    M. Fitzsimons1, M. Bindal2, J. Buggs3, D. Patino4, E. Rogers3, A. Kumar1, A. Lu3

  • Risk Factors for Incisional Hernia Recurrence and Surgical Site Infection in the Transplant Population

    O. Andacoglu1, U. Ozbek2, F. Cheema1, L. Sanchez1, F. Malcher1

  • Risk Factors for Losing Varicella Immunity after Pediatric Kidney Transplantation

    H. Pizzo1, J. Mirocha2, J. Garrison1, P. R. Soni3, S. Nadipuram3, D. Puliyanda1

  • Risk Factors for the Development of Avascular Necrosis: Single Center Experience

    A. Karakok1, A. Velioglu2, I. H. Arikan2, E. Asicioğlu2, S. Tuglular1

  • Risk Factors of Focal Segmental Glomerulosclerosis Recurrence in Pediatric Kidney Transplant Recipients : Single Center Experience

    C. T. Chung, H. Ko, H. Mo, H. Kim, A. Han, S. Min, J. Ha

  • Risk Factors of Invasive Fungal Infections in Liver Transplantation: Systematic Review and Meta-Analysis

    P. Phoompoung1, S. Herrera2, A. Perez Cortes Villalobos1, F. Foroutan1, A. Orchanian-Cheff1, S. Husain1

  • Risk of Histological Relapse in Patients with Monoclonal Gammopathy of Renal Significance after Kidney Transplantation

    A. Bentall1, C. Heybeli2, F. G. Cosio1, M. El Ters1, N. Leung1, M. P. Alexander3

  • Risk of Infectious Complications after GastroIntestinal Surgery in Renal Transplant Recipients

    S. Karhadkar, P. Jacoby, T. Webster, A. Di Carlo

  • Risk of Invasive Fungal Infection after Heart Transplantation

    Z. A. Yetmar1, B. Lahr2, E. Beam3

  • Risk of Tuberculosis in Kidney Transplantation Recipients Compared to Dialysis Patients or General Population: A Nationwide Cohort Study with Matched Controls

    S. Park1, J. Kim2, M. Yu3, J. Lee2, K. Han4, S. Park1, Y. Kim2, D. Kim2, Y. Kim2, H. Lee2

  • Risk Prediction in the Meld-NA Era: The Tremendous Impact of Liver Related Complications

    N. R. Mazumder1, K. Atiemo2, K. Jackson3, A. Daud4, A. Kho3, J. Levitsky1, D. P. Ladner4

  • Risk Stratification in Antibody Incompatible Kidney Transplantation: Can Aggressive Rejection be Avoided?

    S. Punjala1, M. Ibrahim1, N. Vallant1, N. Kessaris1, O. Shaw2, N. Mamode1

  • RN Specialty Practice to Optimize Enteric Hyperoxaluria Management – A Qi Project

    B. M. Amberg, M. R. D'Costa, J. L. Wells-Pittman, A. R. Frodermann, E. M. Dahlen, G. M. Davidson, T. L. Mueller, C. A. Nash, T. I. Schnell, H. Amer, J. C. Lieske

  • RNA Sequencing of Urine RNA Samples for Biomarker Discovery

    K. S. Keslar1, D. Margeta1, M. Abecassis2, J. J. Friedewald2, P. S. Heeger3, R. L. Fairchild1

  • Robot-Assisted versus Open Kidney Transplantation for Morbidly Obese Patients

    S. D. Lee1, B. Rawashdeh2, E. K. McCracken2, L. A. Cantrell3, A. Demirag2, A. Agarwal2, K. L. Brayman2, S. J. Pelletier2, J. Oberholzer2

  • Robotic Assisted Living Donor Nephrectomies: A Safe Alternative to Laparoscopic Technique for Kidney Transplant Donation

    M. Spaggiari1, R. Garcia-Roca2, J. Oberholzer3, K. Tulla1, O. Okoye1, C. Di Bella1, H. Jeon4, I. G. Tzvetanov1, E. Benedetti1

  • Robotic Donor Nephrectomy: A Novel Approach to Improve Living Donor Kidney Transplantation

    R. Shahbazov1, A. Popovic1, D. Friedman2, I. Bandler2, S. Loerzel1, K. Heslin2, R. Hod Duvarai3, B. Gallay4, O. Pankewycz4, M. Laftavi1

  • Role of APC Subsets in Rejection and Graft-Versus-Host-Disease in Intestinal Transplantation

    H. Dhani, N. Svetlicky, J. Kang, S. Moturi, A. Duttargi, K. Khan, C. Matsumoto, T. S. Fishbein, A. Kroemer

  • Role of B-Cell Subsets in Allograft Rejection in Intestinal Transplantation

    H. Dhani, N. Svetlicky, J. Kang, S. Moturi, A. Duttargi, K. Khan, C. Matsumoto, T. Fishbein, A. Kroemer

  • Role of CAR-T Cell Therapy in Post Transplant Lymphoproliferative Disorder

    S. Krishnamoorthy, A. Malone, R. Delos Santos, H. Murad, T. Alhamad

  • Role of Cell Free DNA (Allosure) Testing in Recipients of Kidneys with Sub Optimal Donor Quality

    Y. A. Qazi, W. Mon, M. Smogorzewski

  • Role of Circulating Exosomes in the Induction of Immune Responses Resulting in Cardiac Allograft Rejection in miR155 Knockout Animals

    S. Bansal, Y. Itabashi, M. Smith, R. Bremner, T. Mohanakumar

  • Role of Cross-Dressing in Kidney Transplantation

    D. Zhao, R. Tieu, K. Abou-Daya, A. Williams, M. Oberbarnscheidt, F. Lakkis

  • Role of Genetic Studies in Reclassifying Cause of End Stage Kidney Disease among Kidney Transplant Candidates

    M. El Ters1, F. Pinto e Vairo2, F. C. Fervenza1, M. Alexander3, F. G. Cosio1, H. Amer1, M. Hogan1

  • Role of Innate Allorecognition Pathways in Mouse Kidney and Heart Allograft Rejection

    D. Zhao1, H. Dai1, K. Abou-Daya1, R. Tieu1, A. Williams1, M. Oberbarnscheidt1, X. Li2, F. Lakkis1

  • Role of Peptide Antigen, Antigen-Presenting Cells and CD4 T Cells in Modulating BK Polyomavirus (BKPyV)-Specific CD8 T Cell Responses In Vitro

    M. Wilhelm, A. Kaur, M. Wernli, H. H. Hirsch

  • Role of Tacrolimus Dose Adjustment at Discontinuation of Fluconazole in Liver Transplant

    J. Yau, H. Morris

  • Roles of Calpastatin in Ischemia/Reperfusion Injury in Aged Livers

    J. Kim, C. Lee, W. Chapman

  • Rouleaux Formation in Human Livers During Normothermic Machine Perfusion

    M. Harris1, S. Raigani2, C. Albert3, M. Reschke3, C. Carroll2, J. T. Langford1, C. Edwards4, D. Mulligan4, D. Haakinson1, K. Uygun2, H. Yeh2, G. Tietjen1

  • Routine Human Renal Allograft Biopsies Analyzed for mRNA Content with a Novel Nanostring mRNA Human Organ Transplant (HOT) Panel

    I. Rosales1, R. Smith1, E. Acheampong1, T. Kawai1, T. Tsuji2, K. Hotta3, R. Colvin1

Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences